Jung Rin Lee

6546049, Apr 8, 2003

Sep 28, 1999

09/406352

Jung Woo Lee - Princeton NJ

Sarnoff Corporation - Princeton NJ

H04N 712

37524003, 37524005, 37524004, 37524022

In video compression processing, such as MPEG-2 compression processing, the quantization (Q) matrix used to quantize discrete cosine transform (DCT) coefficients is updated from frame to frame based on a parameterized Q matrix adaptation algorithm. According to the algorithm, the Q matrix for the current frame is generated based on DCT coefficient data from the previously encoded frame of the same type (e. g. , I, P, or B) as the current frame. In particular, the Q matrix is generated using a function based on shape parameters (e. g. , the slope of the diagonal of the Q matrix and/or the convexity of the diagonal of the Q matrix), where the diagonal slope for the Q matrix of the current frame is generated based on the diagonal slope of a DCT map for the previously encoded frame. Before using the generated Q matrix to quantize the DCT coefficients for the current frame, the Q matrix is preferably adjusted for changes in the target mean from the previously encoded frame to the current frame.

6562847, May 13, 2003

Aug 25, 1999

09/383142

Jung S. Lee - Ambler PA

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

H01N 4340

514343, 5462764, 5462681, 546194, 5462784

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O) and R to R are various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimers disease, memory loss or dementia or loss of motor function.

6888001, May 3, 2005

Apr 2, 2003

10/405250

Jung S. Lee - Ambler PA, US

H01N043/40
C07D401/00

546276, 546268, 546194, 546278, 514343

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O)and Rto Rare various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.

6958349, Oct 25, 2005

Mar 31, 2003

10/403186

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Ortho-McNeil Pharmaceuticals, Inc. - Raritan NJ

A61K031/47
C07D215/12
C07D215/16

514314, 546174, 546175, 546177

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

7352825, Apr 1, 2008

Dec 1, 2003

10/725095

Deepak Das - Chatham NJ, US
Jung Ah Lee - Pittstown NJ, US
Shirish Nagaraj - Middletown NJ, US
Anil M. Rao - Hoboken NJ, US

Lucent Technologies Inc. - Murray Hill NJ

H03K 9/00
H03D 1/04

375316, 375346, 375147

The disclosed embodiments relate to a communication system and method. The system may comprise a pre-whitening device that applies pre-whitening data to a received signal from an antenna array to produce a pre-whitened signal, at least one detector that is adapted to recognize a pattern corresponding to a request for access in the pre-whitened signal and compute correlation data corresponding to the pattern, and a threshold detector that determines whether the correlation data exceeds a threshold and indicates that an acknowledgement signal should be transmitted if the threshold is exceeded. The method may comprise the acts of creating a pre-whitened signal by applying pre-whitening data to a received signal, detecting a pattern that corresponds to a request for access in the pre-whitened signal, computing correlation data corresponding to the pattern, determining whether the correlation data exceeds a threshold, and indicating that an acknowledgement signal should be transmitted if the threshold is exceeded.

7358261, Apr 15, 2008

Dec 16, 2004

11/014471

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

A61K 31/47
C07D 215/38

514311, 514312, 514314, 546153, 546176, 546178

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

7435822, Oct 14, 2008

Feb 2, 2005

11/048976

John R. Carson - Norristown PA, US
Jung S. Lee - McLean VA, US

Janssen Pharmaceutica N.V. - Beerse

C07D 401/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00

546125

This invention is directed to 3-(diheteroarylmethylene)-8-azabicyclo[3. 2. 1] octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3. 2. 1] octane derivatives useful as δ-opioid, μ-opioid, or δ-opioid and μ-opioid receptor receptor modulators. Depending on their agonist or antagonist effect, the compounds are useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.

7554952, Jun 30, 2009

Feb 9, 2005

11/054256

Achilles G. Kogiantis - Madison NJ, US
Jung Ah Lee - Pittstown NJ, US
Lawrence H. Ozarow - Morris Township NJ, US

Alcatel-Lucent USA Inc. - Murray Hill NJ

H04Q 7/00

370334, 370337, 370350, 4554522, 455439

A wireless communication system () includes using multiple antennas () for simultaneous transmissions to multiple mobile stations (). A distributed multiple antenna scheduling (DMAS) technique includes selecting a plurality of mobile stations for at least receiving simultaneous transmissions on at least one selected subcarrier from within a carrier bandwidth having orthogonal frequency division multiplexing (OFDM). In a disclosed example, a plurality of mobile stations are selected for each subcarrier within the carrier bandwidth. A disclosed example includes grouping subcarriers together into subsets to reduce computation complexity for determining which mobile stations to select for the simultaneous transmission.